U.K. Regulator Is First to Approve Merck’s Covid-19 Pill

Decision follows ‘rigorous review’ of safety, effectiveness
Approval extends regulator’s streak of quick action on Covid

Merck & Co’s Covid-19 antiviral pill.
Source: Merck & Co.

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Frank Connelly

November 4, 2021 at 11:10 AM UTC

Updated on

November 4, 2021 at 12:15 PM UTC

This article is for subscribers only.

Follow us at @BloombergUK for the latest news and analysis.

Britain’s regulator became the first in the world to approve Merck & Co.’s Covid-19 antiviral pill, describing the treatment as safe and effective following a swift review.